Free Submission Public Relations &
Deutsch English


Just Released: "PharmaPoint: Hemophilia A and B - Current and Future Players"

Print article Print article
2014-01-10 09:10:09 - New Pharmaceuticals market report from GlobalData: "PharmaPoint: Hemophilia A and B - Current and Future Players"

GlobalData has released its pharma report, "PharmaPoint: Hemophilia A and B - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Hemophilia A and B Market. The report identifies and analyses the key companies shaping and driving the global Hemophilia A and B market. The report provides insight into the competitive Hemophilia A and B landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.


* Investigation of current and future market competition for Hemophilia A and B
* Competitor assessment
* Coverage of key

market players and company profiles including business description, financial overview and SWOT analysis.
* Strategic assessment of the Hemophilia A and B sector through market impact analysis, future market scenario and company analysis

Full Report Details at
- ..

Reasons to Get this Report

* Gain a high level view of the trends shaping and driving the Hemophilia A and B Market
* Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
* Create an effective counter-strategy to gain a competitive advantage against those currently in the market
* What's the next big thing in the global Hemophilia A and B market landscape? Identify, understand and capitalize

Companies Mentioned in this Report: Baxter, Biogen Idec, Novo Nordisk, CSL Behring, Bayer, Pfizer

Report Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers - Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 Baxter
4.3.2 Biogen Idec
4.3.3 Novo Nordisk
4.3.4 CSL Behring
4.3.5 Bayer
4.3.6 Pfizer
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Methodology
5.4 Forecasting Methodology
5.4.1 Diagnosed Hemophilia Patients
5.4.2 Percent Drug-Treated Patients
5.4.3 Drugs Included in Each Therapeutic Class
5.4.4 General Pricing Assumptions
5.5 Physicians and Specialists Included in this Study
5.6 About the Authors
5.6.1 Authors
5.6.2 Global Head of Healthcare
5.7 About GlobalData
5.8 Disclaimer

List of Tables

1.1 List of Tables
Table 1: Sales Forecasts ($m) for Hemophilia A and B in the 9MM, 2012-2022
Table 2: Global Hemophilia A and B Market - Drivers and Barriers, 2013
Table 3: Key Companies in the Hemophilia A and B Market, 2013
Table 4: Baxter's Hemophilia Portfolio Assessment, 2013
Table 5: Baxter SWOT Analysis, 2013
Table 6: Biogen Idec's Hemophilia Portfolio Assessment, 2013
Table 7: Biogen SWOT Analysis, 2013
Table 8: Novo Nordisk's Hemophilia Portfolio Assessment, 2013
Table 9: Novo Nordisk SWOT Analysis, 2013
Table 10: CSL Behring's Hemophilia Portfolio Assessment, 2013
Table 11: CSL Behring SWOT Analysis, 2013
Table 12: Bayer's Hemophilia Portfolio Assessment, 2013
Table 13: Bayer SWOT Analysis, 2013
Table 14: Pfizer's Hemophilia Portfolio Assessment, 2013
Table 15: Pfizer SWOT Analysis, 2013
Table 16: Abbreviations
Table 17: Physicians Surveyed

List of Figures

1.2 List of Figures
Figure 1: Global Sales for Hemophilia A and B by Region, 2012-2022
Figure 2: Company Portfolio Gap Analysis in Hemophilia A and B, 2012-2022

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact